Study of Ceftolozane/Tazobactam (MK-7625A) in Japanese Participants With Uncomplicated Pyelonephritis and Complicated Urinary Tract Infection (MK-7625A-014)

NCT02728089 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

115

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Tract Infection (UTI)
Complicated Urinary Tract Infection
Pyelonephritis
Uncomplicated Pyelonephritis

Interventions

DRUG: MK-7625A 1.5 g (ceftolozane 1 g/tazobactam 0.5 g)

Sponsor

Merck Sharp & Dohme LLC